Showing 4771-4780 of 20470 results for "".
- Niraparib Plus Abiraterone in HRR-Deficient mCSPChttps://reachmd.com/news/niraparib-plus-abiraterone-in-hrr-deficient-mcspc/2486864/Key Takeaways Longer radiographic progression-free survival was observed with niraparib plus abiraterone across the prespecified BRCA, HRR effector, and intention-to-treat populations. Overall survival remained immature and numerically favored nirapari
- Benzoyl Peroxide and Malignancy Risk: A Systematic Reviewhttps://reachmd.com/news/benzoyl-peroxide-and-malignancy-risk-a-systematic-review/2486868/Key Takeaways Benzoyl peroxide use for acne was not associated with a statistically significant increase in malignancy risk, including hematologic cancers, in this review. Potential exposure misclassification and limited detail on dosage, duration, and
- Post-Tuberculosis Lung Function in Childrenhttps://reachmd.com/news/post-tuberculosis-lung-function-in-children/2486850/Key Takeaways The review included nine studies involving 875 children with prior PTB; in the seven-study pooled post-treatment z-score analysis, lower FEV₁ and FVC were observed, with relative preservation of the FEV₁/FVC ratio. Children with prior PTB
- Symptom-Based Dosing In Neonatal Opioid Withdrawalhttps://reachmd.com/news/symptom-based-dosing-in-neonatal-opioid-withdrawal/2486860/Key Takeaways In ESC-managed infants, symptom-based dosing was associated with faster medical readiness for discharge than scheduled tapering. In the ESC cohort, treatment initiation and overall length of stay did not differ significantly, and the Finn
- Gestational Weight Gain and Adverse Outcomes in 1.6 Million Womenhttps://reachmd.com/news/gestational-weight-gain-and-adverse-outcomes-in-16-million-women/2486865/Key Takeaways Gestational weight gain was evaluated in relation to adverse maternal and neonatal outcomes in a systematic review and meta-analysis of 40 observational studies including 1,608,711 pregnancies. Gestational weight gain below recommendation
- Age Differences in Acute Chest Pain Outcomes in the EDhttps://reachmd.com/news/age-differences-in-acute-chest-pain-outcomes-in-the-ed/2486852/Key Takeaways Higher age was associated with higher 30-day death or MI and MACE in this cohort. Hospitalization (the primary healthcare utilization outcome) and objective cardiac testing (OCT) were also more common with increasing age after adjustment,
- 2024-2025 COVID-19 Vaccine Effectiveness Against Severe Diseasehttps://reachmd.com/news/2024-2025-covid-19-vaccine-effectiveness-against-severe-disease/2486853/Key Takeaways Updated vaccination was associated with lower odds of COVID-19-associated hospitalization in immunocompetent adults and with higher effectiveness estimates for the most severe in-hospital outcome, especially invasive mechanical ventilation or deat
- Review Charts Anatomically Driven Advances in East Asian Rhinoplastyhttps://reachmd.com/news/review-charts-anatomically-driven-advances-in-east-asian-rhinoplasty/2486869/A recent review published online in Journal of Craniofacial Surgery examines the evolution of nasal tip rhinoplasty in East Asia, highlighting a transition from imported Western techniques to regionally tailored innovations grounded in anatomic and cultural considerations. Nasal t
- Micro-Focused Ultrasound Shows Mid-to-Lower Face Tightening in Pilot Studyhttps://reachmd.com/news/micro-focused-ultrasound-shows-mid-to-lower-face-tightening-in-pilot-study/2486847/Micro-focused ultrasound (MFUS) may improve middle and lower facial laxity with a favorable short-term safety profile, according to a prospective pilot study published in Lasers in Medical Science. The single-arm interventional study enrolled 20 Chinese patients with facial laxity. Each pa
- Nontargeted Hepatitis C Screening Yields More ED Diagnoseshttps://reachmd.com/news/nontargeted-hepatitis-c-screening-yields-more-ed-diagnoses/2486832/Key Takeaways Nontargeted screening was associated with more newly identified hepatitis C infections in this emergency department comparison. Targeted screening produced a higher proportion of new diagnoses among tested patients than nontargeted screen